Literature DB >> 2405660

Management of severe hyponatremia: rapid or slow correction?

F H Cluitmans1, A E Meinders.   

Abstract

Case reports and the literature on the treatment of severe hyponatremia were reviewed. It appeared that the conflicting opinions with respect to the rate of correction of severe hyponatremia could be reduced to not differentiating between acute and chronic hyponatremia, to using different criteria for this distinction, and to differences in treatment strategy. After reviewing the available data in the literature, it is suggested that hyponatremia should be classified as acute whenever the rate of decrease of serum sodium exceeds 0.5 mmol/L/hour. If it is unknown at which rate the hyponatremia has developed, it can be assumed to be acute if within a short period of time (two to three days), large quantities of fluid are ingested orally or administered parenterally, especially hypotonic fluids in the presence of impaired water excretion. In other cases, chronic hyponatremia is probable. It is concluded that acute hyponatremia should be treated without delay and rapidly at a rate of at least 1 mmol/L/hour, to prevent severe neurologic damage or death. With respect to chronic hyponatremia, it appeared that severe neurologic complications almost exclusively occurred in patients who were treated with hypertonic or isotonic saline without the addition of furosemide or an osmotic diuretic agent, resulting in a (rapid) correction rate of 0.5 mmol/L/hour or more. In contrast, patients with severe chronic hyponatremia treated with furosemide and isotonic or hypertonic saline almost uniformly did well after rapid correction. Uneventful recovery is also the rule when severe chronic hyponatremia is corrected slowly, at a rate less than 0.5 mmol/L/hour. On pathophysiologic grounds, and bearing in mind that slow correction was used in the majority of reported patients in the literature with severe chronic hyponatremia who recovered without neurologic complications, this treatment modality is preferable. Whenever the available data do not permit a differentiation between acute or chronic hyponatremia, rapid correction has to be pursued by means of administration of hypertonic or isotonic saline together with furosemide.

Entities:  

Mesh:

Year:  1990        PMID: 2405660     DOI: 10.1016/0002-9343(90)90467-r

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

1.  Comatose state due to severe hyponatremia in a patient with the syndrome of inappropriate antidiuretic hormone secretion.

Authors:  G Krutisch; A Valentin
Journal:  Intensive Care Med       Date:  2001-05       Impact factor: 17.440

2.  Preoperative hyponatremia and cardiopulmonary bypass: yet another factor for cerebral dysfunction?

Authors:  Richard Warwick; Kenneth Palmer; Ian Johnson; Michael Poullis
Journal:  J Extra Corpor Technol       Date:  2010-03

Review 3.  Treatment of Severe Hyponatremia.

Authors:  Richard H Sterns
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-02       Impact factor: 8.237

4.  Encephalopathy due to severe hyponatremia in an ultramarathon runner.

Authors:  J M Clark; F J Gennari
Journal:  West J Med       Date:  1993-08

5.  3-month-old baby presents in acute renal failure, edematous, and with generalized convulsions.

Authors:  P R Dodge
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714

Review 6.  Hyponatraemia: more than just a marker of disease severity?

Authors:  Robert W Schrier; Shailendra Sharma; Dmitry Shchekochikhin
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

7.  Treatment of seizures in the neurologic intensive care unit.

Authors:  Panayiotis N Varelas; Marek Mirski
Journal:  Curr Treat Options Neurol       Date:  2007-03       Impact factor: 3.598

Review 8.  Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs.

Authors:  O Spigset; K Hedenmalm
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

9.  Polydipsia-hyponatraemia syndrome : epidemiology, clinical features and treatment.

Authors:  W V Vieweg; R A Leadbetter
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

10.  Exploring the boundaries of perfusion. Left field: square tubes and current changes!

Authors:  Mike Poullis
Journal:  J Extra Corpor Technol       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.